Assembly Biosciences (ASMB) Competitors $20.66 -0.53 (-2.48%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ASMB vs. OMER, CPIX, LLY, JNJ, ABBV, MRK, PFE, BMY, ZTS, and RPRXShould you be buying Assembly Biosciences stock or one of its competitors? The main competitors of Assembly Biosciences include Omeros (OMER), Cumberland Pharmaceuticals (CPIX), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol Myers Squibb (BMY), Zoetis (ZTS), and Royalty Pharma (RPRX). These companies are all part of the "pharmaceuticals" industry. Assembly Biosciences vs. Its Competitors Omeros Cumberland Pharmaceuticals Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Pfizer Bristol Myers Squibb Zoetis Royalty Pharma Omeros (NASDAQ:OMER) and Assembly Biosciences (NASDAQ:ASMB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment. Which has more volatility and risk, OMER or ASMB? Omeros has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500. Comparatively, Assembly Biosciences has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Is OMER or ASMB more profitable? Omeros has a net margin of 0.00% compared to Assembly Biosciences' net margin of -117.20%. Omeros' return on equity of 0.00% beat Assembly Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets OmerosN/A N/A -55.49% Assembly Biosciences -117.20%-149.01%-39.04% Do insiders and institutionals hold more shares of OMER or ASMB? 48.8% of Omeros shares are owned by institutional investors. Comparatively, 19.9% of Assembly Biosciences shares are owned by institutional investors. 12.9% of Omeros shares are owned by insiders. Comparatively, 5.1% of Assembly Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer OMER or ASMB? In the previous week, Assembly Biosciences had 5 more articles in the media than Omeros. MarketBeat recorded 6 mentions for Assembly Biosciences and 1 mentions for Omeros. Omeros' average media sentiment score of 1.25 beat Assembly Biosciences' score of 0.77 indicating that Omeros is being referred to more favorably in the media. Company Overall Sentiment Omeros Positive Assembly Biosciences Positive Do analysts prefer OMER or ASMB? Omeros currently has a consensus target price of $18.00, suggesting a potential upside of 343.90%. Assembly Biosciences has a consensus target price of $41.33, suggesting a potential upside of 100.02%. Given Omeros' stronger consensus rating and higher probable upside, research analysts clearly believe Omeros is more favorable than Assembly Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omeros 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83Assembly Biosciences 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has stronger valuation & earnings, OMER or ASMB? Assembly Biosciences has higher revenue and earnings than Omeros. Assembly Biosciences is trading at a lower price-to-earnings ratio than Omeros, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmerosN/AN/A-$156.82M-$2.11-1.92Assembly Biosciences$28.52M5.56-$40.18M-$5.58-3.70 SummaryOmeros beats Assembly Biosciences on 11 of the 15 factors compared between the two stocks. Get Assembly Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ASMB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASMB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASMB vs. The Competition Export to ExcelMetricAssembly BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$158.50M$4.15B$5.70B$10.27BDividend YieldN/A1.27%5.72%4.60%P/E Ratio-3.7010.7575.8126.51Price / Sales5.5614.29492.95166.26Price / CashN/A7.5125.8129.90Price / Book3.943.2312.836.31Net Income-$40.18M-$134.23M$3.28B$270.12M7 Day Performance-10.73%-3.96%0.24%2.04%1 Month Performance-18.77%3.45%4.59%6.25%1 Year Performance12.62%32.69%68.69%25.50% Assembly Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASMBAssembly Biosciences3.4586 of 5 stars$20.67-2.5%$41.33+100.0%+17.3%$158.50M$28.52M-3.70100Short Interest ↑OMEROmeros3.969 of 5 stars$4.21+1.0%$18.00+327.6%+3.8%$283.79MN/A-2.00210Positive NewsCPIXCumberland Pharmaceuticals0.6242 of 5 stars$3.31flatN/A+162.0%$49.52M$42.07M-15.0580Positive NewsLLYEli Lilly and Company4.9965 of 5 stars$738.58+1.6%$950.17+28.6%-19.0%$688.27B$53.26B48.2747,000Trending NewsAnalyst ForecastJNJJohnson & Johnson4.6837 of 5 stars$178.30-0.1%$176.29-1.1%+7.2%$429.72B$90.63B19.07138,100Positive NewsAnalyst UpgradeABBVAbbVie4.7909 of 5 stars$209.97-1.2%$214.95+2.4%+12.2%$375.50B$56.33B99.9955,000Trending NewsAnalyst ForecastAnalyst RevisionMRKMerck & Co., Inc.4.9979 of 5 stars$84.11-0.7%$107.44+27.7%-30.0%$211.59B$64.17B12.9675,000Positive NewsPFEPfizer4.9867 of 5 stars$24.55-1.3%$28.12+14.6%-18.1%$141.46B$63.63B13.0681,000Positive NewsBMYBristol Myers Squibb4.8934 of 5 stars$46.68-1.0%$56.38+20.8%-5.7%$95.95B$48.30B18.8234,100Positive NewsZTSZoetis4.824 of 5 stars$151.88-0.9%$202.43+33.3%-23.4%$67.95B$9.26B26.1413,800Positive NewsRPRXRoyalty Pharma4.859 of 5 stars$35.80-0.7%$48.00+34.1%+26.8%$21.04B$2.26B20.6980Positive NewsAnalyst DowngradeHigh Trading Volume Related Companies and Tools Related Companies Omeros Alternatives Cumberland Pharmaceuticals Alternatives Eli Lilly and Company Alternatives Johnson & Johnson Alternatives AbbVie Alternatives Merck & Co., Inc. Alternatives Pfizer Alternatives Bristol Myers Squibb Alternatives Zoetis Alternatives Royalty Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASMB) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assembly Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assembly Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
